Gene: F2RL1
Official Full Name: F2R like trypsin receptor 1provided by HGNC
Gene Summary: This gene encodes a member of the G-protein coupled receptor 1 family of proteins. The encoded cell surface receptor is activated through proteolytic cleavage of its extracellular amino terminus, resulting in a new amino terminus that acts as a tethered ligand that binds to an extracellular loop domain. Activation of the receptor has been shown to stimulate vascular smooth muscle relaxation, dilate blood vessels, increase blood flow, and lower blood pressure. This protein is also important in the inflammatory response, as well as innate and adaptive immunity. [provided by RefSeq, Jun 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00344 | F2RL1 Knockout cell line(293T) | Human | F2RL1 | 1:3~1:6 | Negative | Online Inquiry |
KO37931 | F2RL1 Knockout cell line (HeLa) | Human | F2RL1 | 1:3~1:6 | Negative | Online Inquiry |
KO37932 | F2RL1 Knockout cell line (HCT 116) | Human | F2RL1 | 1:2~1:4 | Negative | Online Inquiry |
KO37933 | F2RL1 Knockout cell line (HEK293) | Human | F2RL1 | 1:3~1:6 | Negative | Online Inquiry |
KO37934 | F2RL1 Knockout cell line (A549) | Human | F2RL1 | 1:3~1:4 | Negative | Online Inquiry |
F2RL1 Gene Knockout Cell Lines are genetically engineered cell models specifically designed to silence the F2RL1 gene, which encodes for the protease-activated receptor 1 (PAR1). This receptor plays a crucial role in various physiological processes, including blood coagulation, inflammation, and pain perception. By employing CRISPR-Cas9 technology, these knockout cell lines effectively eliminate the expression of the F2RL1 gene, enabling researchers to investigate the downstream effects of its absence and to dissect the pathways involved in thromboinflammation—a key focus in cardiovascular and cancer research.
The primary function of F2RL1 Gene Knockout Cell Lines is to serve as a robust platform for understanding the biological implications of PAR1 signaling. By utilizing these cell lines, scientists can study how the loss of PAR1 impacts cellular responses to inflammatory stimuli, evaluate the role of PAR1 in cancer progression, and explore new therapeutic targets for managing associated pathologies. Furthermore, this tool enables high-throughput screening of potential drug candidates that may modulate PAR1-related pathways, thereby offering significant utility in both academic and clinical research settings.
Compared to traditional cell lines that express F2RL1, these knockout models present a unique advantage by providing an unequivocal system that eliminates confounding variables related to receptor activation. Additionally, they can be used in combination with other knockout or knock-in systems to study complex interactions within signaling networks, offering enhanced experimental rigor.
Researchers and clinicians looking to deepen their understanding of the molecular mechanisms of diseases linked to PAR1 will find F2RL1 Gene Knockout Cell Lines invaluable. Their ability to delineate the F2RL1 functions opens avenues for developing targeted therapies, thereby enhancing the potential for clinical translation.
Our company specializes in advanced genetic tools and cell line development. We pride ourselves on providing high-quality biological products that empower scientists to make groundbreaking discoveries in their fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.